NATCO Pharma
₹1,055.65
100
-₹38.6-3.53% Tuesday 10:00
Statistics
Day High
1,103
Day Low
1,052
52W High
1,123.7
52W Low
792.95
Volume
855,939
Avg. Volume
-
Mkt Cap
188.96B
P/E Ratio
12.89
Dividend Yield
0.47%
Dividend
5
Upcoming
Dividends
0.47%Dividend Yield
Feb 26
₹1.5
Nov 25
₹1.5
Aug 25
₹2
Feb 25
₹1.5
Dec 24
₹1.5
10Y Growth
9.6%
5Y Growth
7.39%
3Y Growth
-19.26%
1Y Growth
N/A
Earnings
1JunExpected
Expected EPS
15.608964049764639
Actual EPS
N/A
Financials
42.74%Profit Margin
Profitable88.23BRevenue
37.71BNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NATCOPHARM.NSE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
NATCO Pharma Limited, a pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. It also provides orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, the company offers neurology, cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company provides agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
Show more...
CEO
Mr. Venkaiah Chowdary Nannapaneni M. Pharm, MS.
Employees
4199
Country
India
ISIN
INE987B01026
Listings
0 Comments
Share your thoughts
FAQ
What is NATCO Pharma stock price today?▼
The current price of NATCOPHARM.NSE is ₹1,055.65 INR — it has decreased by -3.53% in the past 24 hours. Watch NATCO Pharma stock price performance more closely on the chart.
What is NATCO Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange NATCO Pharma stocks are traded under the ticker NATCOPHARM.NSE.
Is NATCO Pharma stock price growing?▼
NATCOPHARM.NSE stock has fallen by -3.28% compared to the previous week, the month change is a +10.06% rise, over the last year NATCO Pharma has showed a +25.78% increase.
What is NATCO Pharma market cap?▼
Today NATCO Pharma has the market capitalization of 188.96B
When is the next NATCO Pharma earnings date?▼
NATCO Pharma is going to release the next earnings report on June 01, 2026.
What were NATCO Pharma earnings last quarter?▼
NATCOPHARM.NSE earnings for the last quarter are 8.52 INR per share, whereas the estimation was 5.31 INR resulting in a +60.63% surprise. The estimated earnings for the next quarter are N/A INR per share.
What is NATCO Pharma revenue for the last year?▼
NATCO Pharma revenue for the last year amounts to 88.23B INR.
What is NATCO Pharma net income for the last year?▼
NATCOPHARM.NSE net income for the last year is 37.71B INR.
Does NATCO Pharma pay dividends?▼
Yes, NATCOPHARM.NSE dividends are paid trimesterly. The last dividend per share was 1.5 INR. As of today, Dividend Yield (FWD)% is 0.47%.
How many employees does NATCO Pharma have?▼
As of April 22, 2026, the company has 4,199 employees.
In which sector is NATCO Pharma located?▼
NATCO Pharma operates in the Health & Wellness sector.
When did NATCO Pharma complete a stock split?▼
The last stock split for NATCO Pharma was on November 26, 2015 with a ratio of 5:1.
Where is NATCO Pharma headquartered?▼
NATCO Pharma is headquartered in Hyderabad, India.